首页> 美国卫生研究院文献>other >The mitochondrial Na+/Ca2+exchanger is essential for Ca2+ homeostasis andviability
【2h】

The mitochondrial Na+/Ca2+exchanger is essential for Ca2+ homeostasis andviability

机译:线粒体Na + / Ca2 +交换器对于Ca2 +稳态和可行性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Mitochondrial calcium (mCa2+) has a central role in both metabolic regulation and cell death signalling, however its role in homeostatic function and disease is controversial. Slc8b1 encodes the mitochondrial Na+/Ca2+ exchanger (NCLX), which is proposed to be the primary mechanism for mCa2+ extrusion in excitable cells,. Here we show that tamoxifen-induced deletion of Slc8b1 in adult mouse hearts causes sudden death, with less than 13% of affected mice surviving after 14 days. Lethality correlated with severe myocardial dysfunction and fulminant heart failure. Mechanistically, cardiac pathology was attributed to mCa2+ overload driving increased generation of superoxide and necrotic cell death, which was rescued by genetic inhibition of mitochondrial permeability transition pore activation. Corroborating these findings, overexpression of NCLX in the mouse heart by conditional transgenesis had the beneficial effect of augmenting mCa2+ clearance, preventing permeability transition and protecting against ischaemia-induced cardiomyocyte necrosis and heart failure. These results demonstrate the essential nature ofmCa2+ efflux in cellular function and suggestthat augmenting mCa2+ efflux may be a viabletherapeutic strategy in disease.
机译:线粒体钙(mCa 2 + )在代谢调节和细胞死亡信号传导中都起着核心作用,但是其在稳态功能和疾病中的作用是有争议的 。 Slc8b1编码线粒体Na + / Ca 2 + 交换子(NCLX),被认为是mCa 2 + 挤出的主要机制。可兴奋细胞。在这里,我们显示他莫昔芬诱导的成年小鼠心脏中Slc8b1的缺失导致猝死,不到13%的受影响小鼠在14天后存活。致命性与严重的心肌功能障碍和暴发性心力衰竭相关。从机制上讲,心脏病理学归因于mCa 2 + 超载驱动超氧化物生成和坏死细胞死亡的增加,而遗传抑制线粒体通透性过渡孔的活化可以挽救心脏病理。有条件的转基因证实了NCLX在小鼠心脏中的过表达,具有增加mCa 2 + 清除率,防止通透性转变并防止缺血引起的心肌细胞坏死和心力衰竭的有益作用,从而印证了这些发现。这些结果证明了mCa 2 + 在细胞功能中的外流并提示增强mCa 2 + 外排可能是可行的疾病的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号